Background
==========

Phospholipases A~2~(PLA~2~s) hydrolyse the *sn-2*bond of phospholipids resulting in the release of a fatty acid and lysophospholipid. Mammalian PLA~2~s are classified in three broad categories of secreted PLA~2~(sPLA~2~) and cytosolic PLA~2~s which are either calcium dependent as to their catalytic activity, or calcium independent cytosolic PLA~2~s \[[@B1]\]. Secreted PLA~2~s are small molecular size proteins (14-19 kDa) with a rigid tertiary structure, having five to eight disulfide bonds that probably confer resistance to proteolysis and thermal denaturation \[[@B1],[@B2]\] with a highly conserved catalytic site and a Ca^2+^-binding loop. These secreted PLA~2~s were first detected in snake venom pancreatic juice and in tissues \[[@B3]\]. Secreted PLA~2~s are also expressed in a number of cell types and present in various body fluids. They participate in the first line in antimicrobial defence of the body against bacteria and other pathogens. The extensive literature on sPLA~2~s in inflammatory diseases has been reviewed \[[@B4]-[@B11]\].

The gene of pancreatic PLA~2~-IB was first isolated in 1986 \[[@B12]\] followed in 1989 by the cloning of non-pancreatic PLA~2~-IIA from rheumatoid arthritic synovial fluid \[[@B13]\] and blood platelets \[[@B14]\]. Together with pancreatic PLA~2~-IB, the sPLA~2~-IIA are the best known and biochemically characterized enzymes. Novel sPLA~2~were identified in the 90^th^by screening nucleic acid data bases. Up to now, eleven sPLA~2~s have been cloned: IB, IIA, IIC, IID, IIE, IIF, III, V, X, and XIIA PLA~2~s together with the XIIB PLA~2~-like protein devoid of catalytic activity \[[@B1],[@B15],[@B16]\]. They express different catalytic and binding properties to natural phospholipids \[[@B17],[@B18]\].

Earlier studies have localized sPLA~2~-IIA in the intestine \[[@B19],[@B20]\] and in the synovial fluid of patients with rheumatoid arthritis as well as sPLA~2~released from platelets \[[@B14],[@B21]\]. The concentration levels of PLA~2~-IIA increase in sera of patients suffering from severe acute inflammatory diseases, such as sepsis and bacterial infections \[[@B22],[@B23]\] and acute pancreatitis \[[@B24]\]. The sPLA~2~-IIA was originally localized in Paneth cells of the rat intestine \[[@B25],[@B26]\] and later on in macrophages \[[@B27],[@B28]\]. The two above mentioned cell types are both involved in the antibacterial response.

Later on it was demonstrated that the PLA~2~-IIA from human and mouse, with high activity on phosphatidylglycerol and bearing cationic properties (pI \> 9.0), are highly bactericidal against gram positive bacteria \[[@B29]-[@B33]\] by perturbing the anionic bacterial cell wall \[[@B34]\]. The bacteria digested by the intestinal PLA~2~do not necessarily have to be within the intestinal lumen. Some bacteria specifically invade the intestinal mucosa from the lamina propria, as it has been postulated to occur in Whipple\'s disease \[[@B35]\]. The human PLA~2~-IIA enzyme shows low affinity for zwitterionic interfaces, and in the absence of interfacial binding mammalian membrane hydrolysis is not possible \[[@B36]\].

With the growing interest in chicken diseases, such as avian influenza, we recently focused on bird sPLA~2~to further gain some functional and pathological insights. Ben Bacha et al. \[[@B37]\] have biochemically characterized an active thermo stable PLA~2~-IB from ostrich pancreas (OPLA~2~). Another PLA~2~-IB was also purified from chicken pancreas and biochemically characterized \[[@B38]\]. It was therefore of interest to further study some biochemical and structural properties of avian non-pancreatic PLA~2~to gain more insights into their mode of action on phospholipids and to compare their properties with those of mammalian PLA~2~. We report here, the purification and some biochemical properties of a secreted PLA~2~from chicken intestine (ChPLA~2~-IIA). This work reports also the cloning of the corresponding bird PLA~2~cDNA and the comparison of its deduced amino acid sequence with other known mammalian PLA~2~. A molecular 3D model of ChPLA~2~-IIA is also proposed to explain some biochemical differences of ChPLA~2~-IIA with other intestinal and pancreatic PLA~2~.

Results and discussion
======================

Determination of phospholipase activity
---------------------------------------

The PLA~2~activity was measured titrimetrically at pH 9.0 and at 40°C with a pH-stat, under the standard assay conditions as described previously \[[@B39]\], using egg yolk (0.5% W/V) as substrate, in 30 ml of 150 mM NaCl, 10 mM NaTDC and 10 mM CaCl~2~. The analysis of the purified egg yolk phospholipids by thin layer chromatography revealed the presence of two spots. The major one (90%) corresponds to the phosphatidylcholine (PC, or lecithin) and the second one (10%) phosphatidylethanolamine (PE). These two phospholipids were separated by adsorption chromatography on a silica gel column. Elution was performed using stepwise ratios of chloroform/methanol. We incubated the purified PC or PE samples with ChPLA~2~-IB or ChPLA~2~-IIA respectively and a thin layer chromatography was performed as shown in Figure [1](#F1){ref-type="fig"}. As expected, ChPLA~2~-IB hydrolyzes efficiently PC and PE since the spots of these two phospholipids totally disappeared and a spot of free fatty acid appeared. In contrast, ChPLA~2~-IIA didn\'t hydrolyze PC even after a long incubation period. Interestingly, PE was totally hydrolyzed by ChPLA~2~-IIA similarly to what observed with ChPLA~2~-IB. These analytical results clearly indicate that the hydrolytic activity of ChPLA~2~-IIA, measured with pH-stat using egg yolk as substrate, is mainly due to the hydrolysis of the PE fraction.

![**Thin layer chromatography of PC and PE before or after incubation with ChPLA~2~-IIA or ChPLA~2~-IB**. After solvent migration the silica plate was exposed to iodine vapor to reveal the various spots. Lane (1), PC. Lane (2), PC incubated with PLA~2~from chicken pancreas (PLA~2~-IB) and showing a complete hydrolysis of the PC. Lane (3), PC incubated with PLA~2~from chicken intestine (PLA~2~-IIA). Lane (4), PE. Lane (5), PE incubated with PLA~2~-IB and showing a complete hydrolysis of the PE. Lane (6), PE incubated with PLA~2~-IIA and showing a complete hydrolysis of the PE. Lane (7), free fatty acid C 18:1.](1476-511X-10-27-1){#F1}

Purification of ChPLA~2~-IIA
----------------------------

ChPLA~2~-IIA was purified from the intestine mucosa using an acidic treatment, ammonium sulfate precipitation, followed by two chromatography steps on Sephadex G-50, and Mono-S Sepharose according to the procedure described in Material and Methods (Figure [2](#F2){ref-type="fig"}). The main steps of the purification procedures and flow sheet are summarized in Table [1](#T1){ref-type="table"}. The specific activity of pure ChPLA~2~-IIA reaches 160 U.mg^-1^when egg yolk was used as substrate, at pH 9.0 and at 40°C, in the presence of 10 mM NaTDC, and 10 mM CaCl~2~. The ChPLA~2~-IIA purification yield was about 10%. SDS-PAGE analysis of the purified ChPLA~2~IIA eluted from the Mono-S column show that the enzyme exhibited one homogenous band corresponding to an apparent molecular mass of about 14 kDa (Figure [2](#F2){ref-type="fig"}). The calculated molecular mass, using the amino acid sequence is 13616Da. Furthermore, the calculated isoelectric pH was equal to pH 9.01.

![**Purification of ChPLA2-IIA**. **(A)**Gel filtration chromatography of intestinal ChPLA~2~-IIA on Sephadex G-50. The column (1.5 cm × 34 cm) equilibrated in 20 mM Tris-HCl buffer pH 8.0 containing 20 mM CaCl~2~and 2 mM benzamidine. Elution was performed with the same buffer at a flow rate of 40 ml.h^-1^and 3 ml samples were collected. ChPLA~2~-IIA activity was measured as described in Material and methods section using egg yolk emulsion as substrate. The pooled fractions containing the PLA~2~activity were indicated by horizontal line. **(B)**Mono-S Sepharose chromatography. The column (5 cm × 2 cm) was equilibrated with 20 mM Tris HCl buffer pH 8.0 containing 20 mM CaCl~2~and 2 mM benzamidine; and then washed with the same buffer containing 0.3 M NaCl. Linear salt gradient (0.3 to 1 M NaCl, dotted line) was applied to the column; gradient chamber 75 ml; 2 ml fraction; flow rate, 40 ml/h. The pooled fractions containing the PLA~2~activity were indicated by horizontal line. SDS-PAGE (15%) analysis of pure ChPLA~2~-IIA was inserted in Figure 2B. Lane 1, molecular mass markers (MM); Lane 2, 15 μg of proteins obtained after Sephadex G-50 chromatography; Lane 3, 15 μg of purified ChPLA~2~-IIA, obtained after Mono-S chromatography.](1476-511X-10-27-2){#F2}

###### 

Flow sheet of chicken intestinal phospholipase A~2~purification

  ---------------------------------------------------------------------------------------------------------------------------------------------------------
  Purification Step            **Total Activity (U)**^**a**^   **Total Protein (mg)**^**b**^   Yield (%)   Specific activity (U/mg)   Purification Factor
  ---------------------------- ------------------------------- ------------------------------- ----------- -------------------------- ---------------------
  **Extraction**\              250                             5520                            100         0.045                      1
  **(pH 8.5)**                                                                                                                        

                                                                                                                                      

  **Acidic treatment (pH3)**   123                             205.5                           49          0.6                        13.33

                                                                                                                                      

  **(NH~4~)~2~SO~4~**\         108                             108                             43          1                          22.22
  **Precipitation**\                                                                                                                  
  **(60%)**                                                                                                                           

                                                                                                                                      

  **Sephadex G-50**            95                              6.41                            38          14.8                       328.88

                                                                                                                                      

  **MonoS Sepharose**          25                              0.156                           10          160                        3555
  ---------------------------------------------------------------------------------------------------------------------------------------------------------

a\) 1 Unit: μmole of fatty acid released per min using egg yolk as substrate in the presence of 10 mM NaTDC and in the presence of 10 mM CaCl~2~.

b\) Proteins were estimated by Bradford method \[[@B30]\]. The experiments were conducted in triplicate.

Enzymatic properties of the purified ChPLA~2~-IIA
-------------------------------------------------

### Ca^2+^dependence

It is well established that Ca^2+^is essential for both, catalysis and enzyme binding to the substrate \[[@B40]-[@B42]\]. In order to investigate the effect of Ca^2+^on ChPLA~2~-IIA activity, we studied the variation of hydrolysis rates of egg yolk phospholipids by pure ChPLA~2~-IIA in the presence of various Ca^2+^concentrations (Figure [3A](#F3){ref-type="fig"}). Our results showed that no PLA~2~activity can be detected in the absence of Ca^2+^and in the presence of 10 mM EDTA or EGTA. In the absence of calcium chelators, the specific activity of purified ChPLA~2~increases to reach 160 U.mg^-1^at 10 mM CaCl~2~(Figure [3A](#F3){ref-type="fig"}).

![**Effect of Ca^2+^and NaTDC on ChPLA2-IB and ChPLA2-IIA activities**. **(A)**Effect of Ca^2+^concentration on ChPLA~2~-IIA (black circle) and ChPLA~2~-IB (white circle) activities. Enzyme activity was measured at various concentrations of Ca^2+^using egg yolk emulsion as substrate at pH 9.0 and at 40°C in the presence of 10 mM NaTDC. The star indicates the phospholipase activity measured in the absence of CaCl~2~and in the presence of 10 mM EDTA or EGTA. **(B)**Effect of increasing concentration of bile salts (NaTDC) on ChPLA~2~-IIA (black circle) and ChPLA~2~-IB (white circle) activities. PLA~2~activity was measured using egg yolk emulsion as substrate at pH 9.0 and at 40°C in the presence of 10 mM Ca^2+^.](1476-511X-10-27-3){#F3}

These observations corroborate previous findings with porcine \[[@B20]\], rat \[[@B19]\], and human \[[@B14]\] intestinal PLA~2~. We previously reported that pancreatic chicken PLA~2~-IB requires only 4 mM of CaCl~2~to reach its maximal activity (Figure [3A](#F3){ref-type="fig"} and \[[@B38]\]).

### Bile salts dependence

Several studies have provided evidence that bile salts are tensioactive agents ensuring in their micellar form, the dispersion of the lipolytic products (of hydrolysis,) \[[@B43],[@B44]\]. Along the same line, De Haas et al. reported that micellar forms of the substrate were hydrolysed at a much higher rate than substrates molecularly dispersed by PLA~2~\[[@B45]\]. In this study, we measured the ChPLA~2~-IIA activity at pH 9.0 and at 40°C using egg yolk as substrate in the presence of increasing concentrations of bile salts. As shown in Figure [3B](#F3){ref-type="fig"}, NaTDC was required for ChPLA~2~-IIA activity. ChPLA~2~-IIA was poorly active at concentrations lower than 2 mM of NaTDC. This activity increases with increasing bile salts concentration and the maximal PLA~2~activity was measured in the presence of 10 mM NaTDC. In contrast, we have presently shown, confirming our previous work, that pancreatic chicken PLA~2~-IB was found to be active in the absence of NaTDC and its optimal activity was found to be nearly independent of NATDC (Figure [3B](#F3){ref-type="fig"} and \[[@B38]\]. One has to recall that in the assay using egg yolk emulsion as substrate, the pancreatic PLA~2~hydrolyses both PC and PE whereas the intestinal enzyme hydrolyses only PE.

### Effect of temperature on ChPLA~2~-IIA activity and stability

Figure [4A](#F4){ref-type="fig"} shows that the maximal activity of ChPLA~2~-IIA was measured at 40°C using egg yolk as substrate in the presence of 10 mM Ca^2+^and 10 mM NaTDC. Unlike pancreatic ChPLA~2~-IB \[[@B38]\] which is totally inactivated at high temperature, the ChPLA~2~-IIA maintained about 60% of its activity after 15 min of incubation at 60°C (Figure [4B](#F4){ref-type="fig"}). Comparable results were obtained with mammalian intestinal PLA~2~from various species which show a good stability at high temperature \[[@B46],[@B47]\].

![**Effect of temperature and pH on ChPLA2-IB and ChPLA2-IIA**. Effects of temperature **(A, B)**and pH **(C, D)**on ChPLA~2~-IIA (black circle) and ChPLA~2~-IB (white circle) activities **(A, C)**and stability **(B, D)**. PLA~2~were tested for activity at various temperatures **(A)**and pH **(C)**as described in material and methods. To study the stability of PLA~2~, 1 mg.ml^-1^of each enzyme was incubated during 30 min at various temperatures **(B)**and pH **(D)**. Residual PLA~2~activity was measured using egg yolk as substrate in the presence of 10 mM Ca^2+^and 10 mM NaTDC. For temperature stability studies, enzymes were incubated in 10 mM Tris (pH 8.0) and 10 mM CaCl~2~. For pH stability studies, Tris buffer was replaced by the appropriate buffer for the pH range.](1476-511X-10-27-4){#F4}

### Effects of pH on ChPLA~2~-IIA activity and stability

As shown in Figure [4C](#F4){ref-type="fig"}, the maximal activity of ChPLA~2~-IIA was measured at pH 9.0 and at 40°C using egg yolk as substrate in the presence of 10 mM Ca^2+^and 10 mM NaTDC. Similar results were obtained with ChPLA~2~-IB and human intestinal PLA~2~-IIA. However, the purified ChPLA~2~-IIA was found to be stable between pH 3.0 and 10.0 (Figure [4D](#F4){ref-type="fig"}). In contrast to the ChPLA~2~-IB, which was found to lose its activity when incubated at pH lower than 5 \[[@B38]\], pure ChPLA~2~-IIA maintained about 50% of its activity after 15 min of incubation at pH 3.0 (see Figure [4D](#F4){ref-type="fig"}). It was also reported that porcine \[[@B20]\] rat \[[@B19]\] and human \[[@B14]\] intestinal PLA~2~are stable at low pH values as compared to ChPLA~2~-IIA. Whereas, some pancreatic PLA2-IB are very acid and thermo stable \[[@B37],[@B48]\]

### N-terminal sequence of ChPLA~2~-IIA

The NH2 terminal sequencing of the ChPLA~2~-IIA allowed unambiguously the identification of the first fourteen residues of pure enzyme. Table [2](#T2){ref-type="table"} shows that the N-terminal sequence of ChPLA~2~-IIA has identity at 80% with mouse, 53% with human, and 53% with porcine PLA2-IIA respectively. Pure ChPLA2-IIA exhibits a high degree of homology with mouse intestinal PLA~2~-IIA.

###### 

Alignment of the N-terminal amino-acid sequence of ChPLA~2~-IIA with mouse, human and porcine intestinal phospholipases. Identical aminoacids are in bold, and homologous aminoacids are in italic

  Chicken:       N *I A*Q **F**G I **M I***K*E K **T G K**   (present work)
  -------------- ------------------------------------------- ----------------
  **Mouse:**     N *I A*Q **F**G E **M I***R*L K **T G K**   \[[@B19]\]
                                                             
  **Human:**     N *L V*N **F**H R **M I***K*L T **T G K**   \[[@B14]\]
                                                             
  **Porcine:**   D *L L*N **F**R K **M I***K*L K **T G K**   \[[@B20]\]

Cloning and sequencing of the gene coding ChPLA~2~-IIA
------------------------------------------------------

The cDNA encoding ChPLA~2~-IIA was selectively amplified by RT-PCR from total mRNA extracted from chicken intestine as described in material and methods. The corresponding DNA was ligated into pET 21a(+) vector and used for transformation into *E. coli*DH10B cells. Several clones are selected and some of them contained a recombinant plasmid with a 500 pb EcoRI/XhoI insert. The cDNA sequencing, confirmed that the PCR product corresponds to the gene encoding for the mature ChPLA~2~-IIA (Figure [5](#F5){ref-type="fig"}). The deduced polypeptide sequence of ChPLA~2~-IIA, corresponding to the mature protein, comprises 123 amino acids. ChPLA~2~-IIA shares 45% of identity with human PLA~2~-IIA and 51% of identity with mouse PLA~2~-IIA. Residues of the catalytic diad are conserved in ChPLA~2~-IIA. The 14 cystein residues involved in disulfide bridges in all known PLA~2~IIA are also conserved in ChPLA2-IIA suggesting also the presence of 7 disulfide bridges in its 3D structure.

![**Nucleotide sequence of the cDNA of ChPLA~2~-IIA and the deduced amino acid sequence**. Sequencing was performed in triplicate with three independent PCRs. The amino acid sequence obtained by N-terminal amino-acid sequence of the pure ChPLA~2~-IIA is shown in italic. M1-C18 in bold, signal peptide; Y41-G49 in square, Ca^2+^loop; and H64-D65 with stars, active site.](1476-511X-10-27-5){#F5}

Homology modelling
------------------

To provide an insight into the biochemical properties, the structure model of the ChPLA~2~-IIA was built, using the 3D structure of the hPLA~2~(PDB code: [1N28](1N28)) as template. These two proteins shares 45% amino acid identity. The model of the ChPLA~2~-IIA was then subjected to molecular mechanics optimization using CHARMM27 force-field. Energy minimization (geometry optimization) was performed until the gradient of 0.01 kcal/(Å.mol) was reached. The RMS deviations involving α-carbons between the initial and the optimized models was 0.95 Å. The Ramachandran plot statistics of the final ChPLA~2~-IIA model and of the hPLA~2~, determined using the PROCHECK program, showed that 97.2%, and 100% of the residues were either in the most favored or in the additional allowed regions, respectively.

Overall 3D structure model of ChPLA~2~
--------------------------------------

As shown in Figure [6](#F6){ref-type="fig"}, the ChPLA~2~-IIA has a globular shape with an α/β hydrolase fold stabilized by seven disulfide bridges similar to those present in all group IIA sPLA2. The core structure consists of four α-helices (αA: Ile2-Thr13; αB: Ala17-Gly22, αC: Ala38-Ser55 and αD: Ser81-Thr103) and two short anti-parallel β-strands (β1 : Phe67-Lys70 and β2 : Gln73-Cys76) located between helix αC and αD. The catalytic Ca^2+^ion is coordinated via oxygen atoms of His26 and Gly28 which belong to the Ca^2+^-binding loop and the two oxygen atoms, Oδ1 and Oδ2 of Asp47. The ChPLA~2~-IIA model showed that (O) Gly22, (O) Gly24, (O) Tyr111 and (Oδ1) Asn113 are located at an interaction distance of 2.2 Å with a second Ca^2+^ion. However these residues correspond in ChPLA~2~-IB to Asp24, Gly26, Leu118 and Lys120, respectively. No fourth amino acid was found in a favorable position to interact with this ion in ChPLA~2~-IB due to the substitution of Asn113 (Oδ1) (in ChPLA~2~-IIA) by Lys120 (in ChPLA~2~-IB). This second Ca^2+^ion may help the stabilization of the C-terminal (Tyr111 and Asn113) with the helix αB (Gly22, and Gly24) and furthermore the Ca^2+^-binding loop.

![**3D modelling structure of ChPLA2-IIA**. **(A)**Cartoon representation the 3D model of the mature ChPLA~2~-IIA. Secondary structure elements labels are indicated. α-helices and β-strands are colored in red and yellow, respectively. The catalytic network and the Ca^2+^-binding residues are indicated and shown as sticks. The disulfide-bridges are shown in yellow. **(B)**Cartoon representation of the ChPLA~2~-IIA structure showing amino acids (represented by sticks) interacting with the substrate (PG). The substrate is indicated as a stick representation. The Ca^2+^ions are represented by a blue spheres. This figure was generated using the PYMOL software.](1476-511X-10-27-6){#F6}

Although ChPLA~2~-IIA and ChPLA~2~-IB share seven disulfide bridges, only six of them are structurally conserved. In ChPLA~2~-IB, the disulfide bridge between Cys11 and Cys77 may stabilize the N-terminal α-helix αA with one of the two short strands of an anti-parallel β-sheet (β-wing) (β2). However, in ChPLA~2~-IIA, one new disulfide bridge is formed between Cys48 (belong to helix αC) and C-terminal Cys123.

To get more insight on the stabilization effect of the second calcium ion, molecular dynamics simulations were carried out (1 ns) at 330°K for the minimized models of the ChPLA~2~-IIA in the presence and the absence of this ion. The RMSD value for the backbone atoms was used to understand the response behavior. The 2D-RMSD plot, where the root mean square deviation of every conformation to all others of a simulation is shown, demonstrated that the conformational space sampled by ChPLA~2~-IIA in the simulations was larger in the absence of Ca^2+^ion (Figure [6](#F6){ref-type="fig"}).

Docking
-------

The total accessible surface area of the ChPLA~2~-IIA and ChPLA~2~-IB were 6591 and 6522 Å^2^, respectively. The positive charged surface of the ChPLA~2~-IIA (876 Å^2^, 12.6%) was higher than that of ChPLA~2~-IB (440 Å^2^, 6.7%). Furthermore, the negative charged surfaces of the ChPLA~2~-IIA and ChPLA~2~-IB were 69 Å^2^, (1%) and 399 Å^2^, (6.1%), respectively.

Analysis of PLA~2~structures bound to a substrate can help in understanding the interaction mode of the substrate once located in the catalytic pocket.

The docking of the substrate (PC, PE or PG) to the ChPLA~2~-IIA and the ChPLA~2~-IB protein was performed using the Molegro Virtual Docker v.4.0.2 software, respectively (data not shown). According to the protein-substrate complexes, 13 or 12 residues are in van der vaals contact with the substrate in the case the ChPLA~2~-IIA and ChPLA~2~-IB, respectively. In the case of the ChPLA~2~-IIA, the total interaction energy between the protein and the target substrate is -134.8, -128.4 and -137,9 kJ/mol for PC, PE or PG respectively. In the case of the ChPLA~2~-IB, the total interaction energy is -183.8, -142.3 and -192.2 kJ/mol for PC, PE or PG respectively. These above mentioned interaction energy may help to explain the lack of catalytic activity of the ChPLA~2~-IIA on PC as substrate.

Materials and methods
=====================

Materials
---------

Benzamidine was from Fluka (Buchs, Switzerland), bovine serum albumine (BSA), anhydrous magnesium sulfate, anhydrous sodium sulfate, potassium chloride, sodium chloride, taurodeoxycholic acid sodium salt (NaTDC) and PC were purchased from Sigma Chemical (St. Louis, MO, USA); acrylamide and bis-acrylamide electrophoresis grade were from BDH (Poole, UK), marker proteins and supports of chromatography used for phospholipase purification: Sephadex G-50, MonoS sepharose, were from Pharmacia (Uppsala, Sweden); protein sequencer Procise 492 equipped with 140 C HPLC system provided from Applied Biosystems (Roissy, France); pH-stat was from Metrohm (Herisau, Switzerland).

All enzymes and reagents used in DNA manipulations were from Promega and Invitrogen (Paris, France). Oligonuclotides were synthesized by Invitrogen. E. coli strain DH10B was used as cloning host for the gene part encoding the mature phospholipase. PCR products were purified using the Wizard PCR Preps DNA purification System (Promega).

Thin-layer Silica Gel 60 plates (10 × 20 cm from Merck) were used for the separation of lipids. Lipid standards (α-L-oleic acid C 18:1) and silica gel 60 powders (70-230) were from Sigma-Aldrich (Steinheim, Germany). All solvents with HPLC grade were purchased from SDS (Peypin, France).

Lipid extraction, separation and analysis
-----------------------------------------

Ten micrograms of purified ChPLA~2~-IB and purified ChPLA~2~-IIA were incubated respectively with 25 μM of pure phosphatidylcholine (PC) and phosphatidylethanol (PE) dispersion in 1 ml buffer (10 mM Tris HCl, 10 mM NaTDC and 10 mM CaCl~2~) at 37°C for 10 minutes. Lipolysis was stopped by adding 200 μl of 1 M HCL and mixing vigorously with 5 ml of chloroform/methanol mixture (2:1, v/v) in a 15 ml glass tube with a Teflon-lined screw cap. Lipids were immediately extracted as follows: after separation phases, the lower organic phase was transferred to a 15-ml test tube and dried over anhydrous magnesium sulphate. Once MgSO~4~had precipitated, the clear organic phase was removed by centrifugation and stored at -20°C before TLC analysis.

To separate lipid classes, 1 to 50 μl of lipid extracts or lipid standards at known concentrations were first spotted onto a thin-layer silica plate. The elution of the lipids was then performed in one step with a chloroform/methanol/water (65/25/4, v/v/v) solvent mixture. Following chromatography, the plates were dried at room temperature for 10 min then immediately placed in the iodine.

Enzyme samples
--------------

The intestine from chicken was collected from a local slaughterhouse (Sfax, Tunisia). Immediately after slaughter, the most distal intestine was opened on a glass plate on ice. The content of each ileal segment was flushed twice with 100 ml of 0.15 M NaCl. Adherent mesentery was removed as completely as possible.

Purification of ChPLA~2~-IIA
----------------------------

Fifty grams of chicken intestine mucosa were suspended in 50 ml of buffer A (0.01 M Tris-HCl pH 8, 0.15 M NaCl, 0.02 M CaCl~2~and 4 mM Benzamidine), and ground mechanically twice for 30 s at room temperature using the Waring Blendor system. Then, the mixture was stirred in a cold room for 1 h and centrifuged during 30 min at 12.000 rpm. The total PLA~2~intestine activity obtained was 250 U.

Acidic treatment
----------------

To inactivate proteins from the pancreatic juice and secreted into the intestine, the supernatant was brought to pH 3.0 by adding 6 N HCl under gentle stirring at 0°C. Insoluble denatured proteins were removed by centrifugation during 30 min at 12.000 g and the clear supernatant was adjusted to pH 8.0 with 4 N NaOH. The recovery of PLA~2~activity was of about 50%.

Ammonium sulphate precipitation
-------------------------------

The supernatant (55 ml, 123 U) was brought to 60% saturation with solid ammonium sulphate under stirring conditions and maintained during 45 min at 4°C. After centrifugation for 30 min at 12.000 g and at 4°C, the precipitated PLA~2~was resuspended in 2 ml of buffer A containing 2 mM benzamidine. Insoluble material was removed by centrifugation for 10 min at 24.000 g. The recovery of PLA~2~activity was about 45%.

Filtration on Sephadex G-50
---------------------------

The sample containing PLA~2~activity (4 ml, 108 U) was loaded on a column of sephadex G-50 (34 cm × 1.5 cm) equilibrated with buffer B (20 mM Tris-HCl, pH 8 and 20 mM CaCl~2~). Elution of proteins was performed with the same buffer at 40 ml.h^-1^. The fractions containing the PLA~2~activity eluted between 1.5 and 1.8 void volumes were pooled (Figure [2A](#F2){ref-type="fig"}).

Cation exchange chromatography
------------------------------

The pooled fractions of Sephadex G-50 column containing PLA~2~activity were poured into a Mono-S column (5 cm × 2 cm) equilibrated with buffer B. Under these conditions, the enzyme is adsorbed to the anionic support and the column was washed with 60 ml of the same buffer containing 0.3 M NaCl. ChPLA~2~-IIA was eluted by a linear salt gradient (0.3-1 M) NaCl as shown in Figure [2B](#F2){ref-type="fig"}.

Analytical methods
------------------

Protein concentration was determined as described by Bradford et al. \[[@B49]\] using BSA $(\underset{1\text{cm}}{\overset{1\%}{\text{E}}} = 6.7)$ as reference.

Analytical polyacrylamide gel electrophoresis of proteins in the presence of sodium dodecyl sulfate (SDS-PAGE) was performed by the method of Laemmli \[[@B50]\]. The proteins were stained with Coomassie brilliant blue.

Amino acid sequencing
---------------------

The N-terminal sequence was determined by automated Edman\'s degradation, using an Applied Biosystems Protein Sequencer Procise 492 equipped with 140C HPLC system.

Bacterial starins, plasmids and media
-------------------------------------

*E. coli*strain DH10B was used as cloning host for the gene part encoding for the mature PLA~2~. *E. coli*strain was grown in Luria-Bertani medium, supplemented with 100 μg.ml^-1^ampicilline whenever plasmid maintenance was required. The plasmid pET21a(+) (Novagen) was used as cloning vector.

cDNA synthesis and amplification
--------------------------------

Total mRNAs were isolated from chicken intestine using the single step guanidine isothiocyanate/phenol/chloroform isolation method as described by Chomczynski and Sacchi \[[@B51]\]. ChPLA~2~-IIA cDNA was obtained from total mRNAs by the reverse transcription procedure (Promega). First strand cDNAs were prepared using 10 μg of total mRNAs as template (heat-denaturated for 5 min at 70°C,) 200 U MMLV reverse transcriptase (Invitrogen), 20 pmol of each deoxynucleoside triphosphate, and 20 pmol of each primer: forward primer, 5\'- GAA TTC ATG AAG CTC C TG GTG CTC CT C -3\' and reverse primer, 5\'- CT C GAG CTA GCA AGA GGG ACG TGA GCC -3\'. The N-terminal primer was predicted, from the N-terminal sequence of the ChPLA~2~; however the C-terminal primer was deduced from the genome of *Gallus gallus*(GenBank accession number: [XP 424364](XP 424364)). Reverse transcription was carried out in a total reaction volume of 20 μl for 5 min at room temperature and 60 min at 42°C. The cDNA/RNA heteroduplex was then denaturated at 70°C for 15 min and cooled on ice.

Cloning of the mature PLA~2~gene
--------------------------------

Amplification of the specific ChPLA~2~-IIA cDNA was carried out by PCR using the single strand cDNAs as template with the forward and reverse primers previously described. PCR was performed in a 0.2 ml Eppendorf tube with a Gene Amp^®^PCR System 2700. The PCR mixture contained 20 pmol of both primers, 20 pmol of each deoxynucleoside triphosphate, 5 U pfx polymerase and polymerisation buffer in final volume of 100 μl. The single strand cDNAs were directly used as template. The thermal profile involved 35 cycles of denaturation at 94°C for 1 min, primer annealing at 60°C for 1 min, and extension at 72°C for 3 min. The PCR product (500 pb) was isolated and ligated into the EcoRI and XhoI linearised and dephosphorylated pET21a(+) vector, according to the manufacturer\'s protocol (Promega). Protoplasts of *E. coli*DH10B were transformed with the ligation mixture. The resulting recombinant plasmid was named pChPLA~2~. The presence of the appropriated insert was verified by restriction analysis. DNA sequences were elucidated by the dideoxynucleotide chain termination method according to a cycle sequencing protocol using thermosequenase (Amersham Pharmacia Biotech). The sequencing reactions were analysed with the DNA sequencer ABI PRISM 3100/3100-Avant Genetic Analyser (California, USA). It was performed three times, using the recombinant vector pChPLA~2~as template with T7 promoter primer and the T7 reverse primer (Invitrogen).

Software for infrastructure
---------------------------

The sequence alignment was performed with BioEdit Version 4.8.4 software. The Molecular Operating Environment 2008.10 (MOE) software was used for homology modelling, molecular dynamics and structures visualization. Models were stereochemically evaluated by the program PROCHECK. The Visualization was performed with PyMol version 0.99beta06. Figures were generated by PyMol program.

Homology Modelling
------------------

The 3-D coordinates of the human group IIA secreted PLA~2~(hPLA~2~) (PDB code: [1N28](1N28)) was extracted from the Protein Data Bank <http://www.rcsb.org>. The hPLA~2~structure was used as template to build a model of the ChPLA~2~-IIA by using the structure-modelling program Molecular Operating Environment 2008.10. The model was then subjected to molecular mechanics optimization using CHARMM27 force field, until a gradient of 0.01 kcal/(Å.mol) was reached.

Docking
-------

The 1,2-dioctylcarbamoylglycero-3-O-phosphatidylcholine (PC), 1,2-dioctylcarbamoylglycero-3-O-phosphatidylethanolamine (PE) and 1,2-dioctylcarbamoylglycero-3-O-phosphatidylglycerol (PG) were modelled by the Molecular Operating Environment 2008.10 (MOE) software using a *Simplified Molecular Input Line Entry Specification (SMILES)*. The Molegro Virtual Docker v.4.0.2 software was used for docking substrates, PC, PE or PG to the ChPLA~2~-IIA and the ChPLA~2~-IB protein, respectively.

The potential binding sites (also referred to as cavities or active sites) was being identified using the built-in cavity detection algorithm, molecular surface with 0.5 Å grid resolutions and 1.2 Å Probe size.

After preparation of the protein and the ligand, the docking was performed using MolDock Score function, MolDock SE search algorithm, 10 runs, energy minimization and optimize H-Bonds after docking, 2500 iterations and 500 steps Simplex Evolution to generate the best five poses scores which were visually analyzed. Only one of these poses correctly bind to the active site with a high score was used. The protein-substrate complex was then subjected to molecular mechanics optimization using CHARMM27 force field as described previously. The Score of the final protein-substrate complex was evaluated using the total interaction energy between the active site and the substrate.

Statistical analysis
--------------------

All the results in figures and text are the average of at least three replicate experiments. They were statistically analyzed with SPSS software (version 100), using the Duncan test performed after analysis of variance (ANOVA).

Abbreviation
============

PLA~2~: phospholipase A2; sPLA~2~: secreted PLA~2~; ChPLA~2~-IB: Group IB chicken pancreatic PLA~2~; ChPLA~2~-IIA : Group IIA chicken intestinal PLA~2~; hPLA~2~-IIA: Group IIA human PLA~2~; NaTDC: taurodeoxycholic acid sodium salt; PC: phosphtidylcholine; PE: phosphatidylethanolamine; TLC: thin layer chromatography; ns: nanosecond. MMLV: Moloney murine leukemia virus.
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